| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Bleeding disorders: making strides towards treatment for all
|
The Lancet Haematology,
|
|
|
7 |
8 |
p. e551
|
artikel
|
| 2 |
Cardiovascular adverse events following treatment for non-Hodgkin lymphoma
|
Jayaraj, Rama
|
|
|
7 |
8 |
p. e557
|
artikel
|
| 3 |
Cardiovascular adverse events following treatment for non-Hodgkin lymphoma – Authors' reply
|
Linschoten, Marijke
|
|
|
7 |
8 |
p. e557-e558
|
artikel
|
| 4 |
Correction to Lancet Haematol 2020; 7: e534–40
|
|
|
|
7 |
8 |
p. e560
|
artikel
|
| 5 |
Endothelial cells orchestrate COVID-19 coagulopathy
|
O'Sullivan, Jamie M
|
|
|
7 |
8 |
p. e553-e555
|
artikel
|
| 6 |
Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study
|
Goshua, George
|
|
|
7 |
8 |
p. e575-e582
|
artikel
|
| 7 |
Following-up allogeneic transplantation recipients during the COVID-19 pandemic
|
Lupo-Stanghellini, Maria Teresa
|
|
|
7 |
8 |
p. e564-e565
|
artikel
|
| 8 |
HIV-associated Burkitt lymphoma
|
Atallah-Yunes, Suheil Albert
|
|
|
7 |
8 |
p. e594-e600
|
artikel
|
| 9 |
Is venous thromboembolism a preventable cause of death?
|
Schulman, Sam
|
|
|
7 |
8 |
p. e555-e556
|
artikel
|
| 10 |
Management of anticoagulant-refractory thrombotic antiphospholipid syndrome
|
Cohen, Hannah
|
|
|
7 |
8 |
p. e613-e623
|
artikel
|
| 11 |
Mortality risk associated with venous thromboembolism: a systematic review and Bayesian meta-analysis
|
Klemen, Nicholas D
|
|
|
7 |
8 |
p. e583-e593
|
artikel
|
| 12 |
Safety and activity of selinexor in patients with myelodysplastic syndromes or oligoblastic acute myeloid leukaemia refractory to hypomethylating agents: a single-centre, single-arm, phase 2 trial
|
Taylor, Justin
|
|
|
7 |
8 |
p. e566-e574
|
artikel
|
| 13 |
Special considerations in the management of adult patients with acute leukaemias and myeloid neoplasms in the COVID-19 era: recommendations from a panel of international experts
|
Zeidan, Amer M
|
|
|
7 |
8 |
p. e601-e612
|
artikel
|
| 14 |
Subcutaneous versus intravenous daratumumab in multiple myeloma
|
Shibusawa, Motoharu
|
|
|
7 |
8 |
p. e558
|
artikel
|
| 15 |
Subcutaneous versus intravenous daratumumab in multiple myeloma – Authors' reply
|
Mateos, Maria-Victoria
|
|
|
7 |
8 |
p. e559
|
artikel
|
| 16 |
Sudden severe thrombocytopenia in a patient in the recovery stage of COVID-19
|
Chen, Wanxin
|
|
|
7 |
8 |
p. e624
|
artikel
|
| 17 |
Tailoring care for patients with haematological malignancies
|
Guan, Jennifer Huey Chen
|
|
|
7 |
8 |
p. e559
|
artikel
|
| 18 |
25th European Hematology Association Annual Congress
|
Cookson, Emma
|
|
|
7 |
8 |
p. e561-e562
|
artikel
|
| 19 |
Treating myelodysplastic syndromes by nuclear transport inhibition
|
Sockel, Katja
|
|
|
7 |
8 |
p. e552-e553
|
artikel
|
| 20 |
Vania Hungria—treating myeloma with restricted resources
|
Kirby, Tony
|
|
|
7 |
8 |
p. e563
|
artikel
|
Tijdschrift beschrijving